The US FDA has approved Israeli biotech Teva’s generic version of the EpiPen auto-injector for emergency treatment for those suffering with “anaphylactic” allergic reactions. Frantic parents in the US have been reporting a nationwide shortage of the original Mylan NV “brand” EpiPen.

http://www.jewishpress.com/news/us-news/teva-shares-skyrocket-after-fda-approves-us-subsidiarys-generic-epipen/2018/08/20/